Search
for
Sort by
Research 391–420 of 1000+
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Idiopathic Hirsutism*
- Androgens in women
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- Topical Application of Ketoconazole Stimulates Hair Growth in C3H/HeN Mice
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Immunoregulatory mechanisms and stress hormones in psoriasis (part 1)
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Hirsutism
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- The eosinophilia-myalgia syndrome
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Management of androgenetic alopecia
- Geriatric Dermatologic Therapy
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- Alopecia: managing the basics
- Alopecia and its medical management
- The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients
- The expression of the gene <i>asebia</i> in the laboratory mouse: 3. Sebaceous glands
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Clinical use of 5α-reductase inhibitors
- The Skin and Subcutaneous Tissues
- Management OF Patients with Polycystic Ovary Syndrom